Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.

Griggio V, Vitale C, Todaro M, Riganti C, Kopecka J, Salvetti C, Bomben R, Dal Bo M, Magliulo D, Rossi D, Pozzato G, Bonello L, Marchetti M, Omedè P, Kodipad AA, Laurenti L, Del Poeta G, Mauro FR, Bernardi R, Zenz T, Gattei V, Gaidano G, Foà R, Massaia M, Boccadoro M, Coscia M.

Haematologica. 2019 Jul 9. pii: haematol.2019.217430. doi: 10.3324/haematol.2019.217430. [Epub ahead of print]

2.

HIF-α factors as potential therapeutic targets in leukemia.

Magliulo D, Bernardi R.

Expert Opin Ther Targets. 2018 Nov;22(11):917-928. doi: 10.1080/14728222.2018.1538357. Epub 2018 Oct 27. Review.

PMID:
30345855
3.

Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia.

Magliulo D, Bernardi R, Messina S.

Front Oncol. 2018 Jul 19;8:255. doi: 10.3389/fonc.2018.00255. eCollection 2018. Review.

4.

H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC.

Carotenuto M, De Antonellis P, Liguori L, Benvenuto G, Magliulo D, Alonzi A, Turino C, Attanasio C, Damiani V, Bello AM, Vitiello F, Pasquinelli R, Terracciano L, Federico A, Fusco A, Freeman J, Dale TC, Decraene C, Chiappetta G, Piantedosi F, Calabrese C, Zollo M.

Oncotarget. 2014 Jul 30;5(14):5736-49.

5.

Early targets of miR-34a in neuroblastoma.

De Antonellis P, Carotenuto M, Vandenbussche J, De Vita G, Ferrucci V, Medaglia C, Boffa I, Galiero A, Di Somma S, Magliulo D, Aiese N, Alonzi A, Spano D, Liguori L, Chiarolla C, Verrico A, Schulte JH, Mestdagh P, Vandesompele J, Gevaert K, Zollo M.

Mol Cell Proteomics. 2014 Aug;13(8):2114-31. doi: 10.1074/mcp.M113.035808. Epub 2014 Jun 9.

Supplemental Content

Loading ...
Support Center